Pinnacle Wealth Management Group, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Pinnacle Wealth Management Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$83.14 - $145.99 $133,024 - $233,584	1,600 New	1,600 $233,000
Q1 2022 Apr 21, 2022	SELL	$110.08 - $142.92 $176,128 - $228,671	-1,600 Closed	0 $0
Q4 2021 Mar 15, 2022	BUY	$99.73 - $148.48 $159,568 - $237,567	1,600 New	1,600 $220,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pinnacle Wealth Management Group, Inc. with notifications on news.